Skip to main content

Table 1 Socio-demographic and clinical characteristics of chronic hepatitis B patients

From: Significant impairment of health-related quality of life in mainland Chinese patients with chronic hepatitis B: a cross-sectional survey with pair-matched healthy controls

 

Overall (n = 460)

Chronic hepatitis B (n = 323)

Compensated cirrhosis (n = 54)

Decompensated cirrhosis (n = 83)

Age (years, mean ± SD)

35.8 ± 12.8

31.5 ± 10.9

43.0 ± 10.3

47.4 ± 11.7

Sex (%)

    

Male

66.3

65.6

72.2

65.1

Female

33.7

34.4

27.8

34.9

Occupation (%)

    

Peasants

33.3

22.6

48.1

65.1

Service and commercial workers

17.0

18.9

14.8

10.9

Enterprise and institution staff

13.3

14.9

14.8

6.0

Unemployees

13.2

16.1

5.6

7.2

Self-employed persons

8.0

9.3

7.4

3.6

Students

7.4

10.5

0.0

0.0

Others

7.8

7.7

9.3

7.2

Education attainment (%)

    

No schooling and primary

13.7

9.6

20.4

25.3

Secondary

67.6

67.2

66.7

69.9

Tertiary

18.7

23.2

12.9

4.8

Marital status (%)

    

Married

71.3

61.9

96.3

91.6

Other marital status

28.7

38.1

3.7

8.4

Annual per capita household income (Chinese $, %)

    

<5000

51.3

45.5

61.1

67.5

5000–9999

24.1

27.3

18.5

15.7

≥10000

24.6

27.2

20.4

16.8

Duration of illness (years, mean ± SD)

6.1 ± 6.9

6.0 ± 6.5

6.4 ± 6.7

6.3 ± 8.2

Currently taken anti-viraltreatment (%)

    

No

61.1

67.2

50.0

44.6

Yes

38.9

32.8

50.0

55.4

Liver function tests*

    

ALT (U/L, mean ± SD)

61.9 ± 95.0

62.1 ± 100.2

52.4 ± 40.9

70.4 ± 83.1

TBIL (umol/L, mean ± SD)

19.7 ± 20.3

16.5 ± 7.3

24.8 ± 13.7

46.7 ± 60.4

ALB (g/L, mean ± SD)

44.1 ± 4.8

45.0 ± 4.0

42.7 ± 4.7

36.0 ± 4.6

  1. ALT, alanine aminotransferase; TBIL, total bilirubin; ALB, albumin.
  2. *Only including 375 patients receiving liver function tests: 311, 34 and 30 in chronic hepatitis B, compensated cirrhosis and decompensated cirrhosis groups, respectively.
  3. Significant difference among three patient groups (P < 0.05).